Laurie Gheddar
Research Subjects
Research Interests
Laurie Gheddar has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Pascal Kintz
X-Pertise Consulting , Mittelhausbergen , France
29 shared publications - Alice Ameline
Institut de Médecine légale Strasbourg France
13 shared publications Jean-Sébastien Raul
Institute of Legal Medicine, Strasbourg, France
13 shared publicationsJean‐Sébastien Raul
Institut de Médecine légale Strasbourg France
10 shared publicationsPascal Kintz
Institut de Médecine légale Strasbourg France
7 shared publicationsAdeline Blanchot
Institut de Médecine légale Strasbourg France
5 shared publications
Latest Publications
- 17 August 2025
- Published by Wiley in Drug Testing and Analysis
- Vol. 17 (12) , 2308-2313
Testing for Meldonium, a Doping Agent, in Human Hair
Meldonium has been developed in the 70s in Latvia and is currently used in a limited number of countries for heart‐related diseases, such as heart attack, failure, or angina pectoris. Due to its metabolic properties (decrease of lactate production, increase of glycogen use, and protective action again oxidative stress), meldonium has been abused by numerous athletes to enhance their performance. The drug has been prohibited by the World Anti‐Doping Agency since 2016 and is on the S4.4.3 list (metabolic modulators) of the prohibited substances at all times. As athletes can challenge their anti‐doping violation involving meldonium, there is an interest in testing for it in hair in order to document their pattern of exposure. Such hair application can be complicated to develop, as meldonium has a chemical formula close to an amino acid and presents an ionized fraction, which are limiting factors for drug incorporation into hair. Liquid chromatography coupled to tandem mass spectrometry was used. The drug was extracted from hair after methanol incubation in an ultrasound bath and separation on a BEH HILIC column. Linearity was verified from 0.5 to 100 pg/mg ( R 2 = 0.9943). The limit of detection was 0.1 pg/mg. Although their meldonium regimen was unknown, the drug was identified in the proximal hair segment (0 to 1 cm) of three consumers at 0.7, 6.1, and 17 pg/mg, highlighting for the first time the incorporation in hair of this molecule.
- 17 August 2025
- Published by Wiley in Drug Testing and Analysis
- Vol. 17 (12) , 2308-2313
Testing for Meldonium, a Doping Agent, in Human Hair
Meldonium has been developed in the 70s in Latvia and is currently used in a limited number of countries for heart‐related diseases, such as heart attack, failure, or angina pectoris. Due to its metabolic properties (decrease of lactate production, increase of glycogen use, and protective action again oxidative stress), meldonium has been abused by numerous athletes to enhance their performance. The drug has been prohibited by the World Anti‐Doping Agency since 2016 and is on the S4.4.3 list (metabolic modulators) of the prohibited substances at all times. As athletes can challenge their anti‐doping violation involving meldonium, there is an interest in testing for it in hair in order to document their pattern of exposure. Such hair application can be complicated to develop, as meldonium has a chemical formula close to an amino acid and presents an ionized fraction, which are limiting factors for drug incorporation into hair. Liquid chromatography coupled to tandem mass spectrometry was used. The drug was extracted from hair after methanol incubation in an ultrasound bath and separation on a BEH HILIC column. Linearity was verified from 0.5 to 100 pg/mg ( R 2 = 0.9943). The limit of detection was 0.1 pg/mg. Although their meldonium regimen was unknown, the drug was identified in the proximal hair segment (0 to 1 cm) of three consumers at 0.7, 6.1, and 17 pg/mg, highlighting for the first time the incorporation in hair of this molecule.
- 13 August 2025
- Published by Wiley in Journal of Forensic Sciences
- Vol. 70 (6) , 2594-2599
Acetaminophen pharmacobezoar following a massive suicidal ingestion
A 61‐year‐old woman died in intensive care 3 days after a massive acetaminophen intoxication with suicidal intent. Investigations at the scene revealed at least 350 empty 500 mg capsule shells, whose content had presumably been consumed. A forensic autopsy, whole‐body computed tomography, toxicological screening, and histopathological analysis were performed. The postmortem CT imaging and autopsy revealed a 10 × 9 × 7 cm pharmacobezoar in the gastric lumen. The formation of such a concretion is unusual for a moderately water‐soluble drug such as acetaminophen. However, the massive amount of drug ingested and simultaneous alcohol consumption may have contributed to the phenomenon. Magnesium stearate, present as an excipient, may have also concurred by lowering the drug's solubility. The toxicological analysis identified a toxic acetaminophen femoral blood level of 690 mg/L, suggesting delayed absorption of the substance due to the bezoar. This case supports the hypothesis that acetaminophen pharmacobezoars may be responsible for the Bactrian (or “double‐hump”) pharmacokinetics sometimes observed in massive overdoses. Second, while the cause of death was attributed to acetaminophen toxicity, no liver necrosis was observed on histopathological analysis, casting doubt on the hypothesis of acute liver failure. Although the present report is limited by the unavailability of the medical records, it suggests that the intoxication may have caused death through another mechanism.
- 13 August 2025
- Published by Wiley in Journal of Forensic Sciences
- Vol. 70 (6) , 2594-2599
Acetaminophen pharmacobezoar following a massive suicidal ingestion
A 61‐year‐old woman died in intensive care 3 days after a massive acetaminophen intoxication with suicidal intent. Investigations at the scene revealed at least 350 empty 500 mg capsule shells, whose content had presumably been consumed. A forensic autopsy, whole‐body computed tomography, toxicological screening, and histopathological analysis were performed. The postmortem CT imaging and autopsy revealed a 10 × 9 × 7 cm pharmacobezoar in the gastric lumen. The formation of such a concretion is unusual for a moderately water‐soluble drug such as acetaminophen. However, the massive amount of drug ingested and simultaneous alcohol consumption may have contributed to the phenomenon. Magnesium stearate, present as an excipient, may have also concurred by lowering the drug's solubility. The toxicological analysis identified a toxic acetaminophen femoral blood level of 690 mg/L, suggesting delayed absorption of the substance due to the bezoar. This case supports the hypothesis that acetaminophen pharmacobezoars may be responsible for the Bactrian (or “double‐hump”) pharmacokinetics sometimes observed in massive overdoses. Second, while the cause of death was attributed to acetaminophen toxicity, no liver necrosis was observed on histopathological analysis, casting doubt on the hypothesis of acute liver failure. Although the present report is limited by the unavailability of the medical records, it suggests that the intoxication may have caused death through another mechanism.
- 19 April 2025
- Published by Springer Nature in Forensic Toxicology
- Vol. 43 (2) , 395-399
Non-consensual administration of mifepristone for hidden abortion: a rare case of drug-facilitated crime
Purpose In this paper, the authors report a hidden administration of mifepristone, an antiprogestogen used in abortion procedure, by the boyfriend of a pregnant woman. After drinking an iced tea, the woman experienced pelvic cramps and then expulsed products of conception. Due to conflicts in the couple, she suspected a surreptitious administration of an abortion medicine and reported the fact to the police. Methods Urine was collected 3 days after the event, while a strand of head hair was collected 1 month later. Urine and hair samples were tested for mifepristone using a liquid chromatography system coupled to tandem mass spectrometry. The limits of detection and quantification were 0.05 and 0.1 ng/mL for urine and 0.5 and 1 pg/mg for hair, respectively. Results Urine and the hair segment corresponding to the period of the event were positive for mifepristone at 0.4 ng/mL and 1.4 pg/mg, respectively. Conclusion The presence of mifepristone in both biological specimens demonstrates that the woman was exposed to the drug at the period of the event. The findings of this case make a valuable contribution to the literature, addressing an important gap regarding the concentrations found in biological matrices. There is a few data available in the literature, and these results help to expand knowledge on the subject.
- 19 April 2025
- Published by Springer Nature in Forensic Toxicology
- Vol. 43 (2) , 395-399
Non-consensual administration of mifepristone for hidden abortion: a rare case of drug-facilitated crime
Purpose In this paper, the authors report a hidden administration of mifepristone, an antiprogestogen used in abortion procedure, by the boyfriend of a pregnant woman. After drinking an iced tea, the woman experienced pelvic cramps and then expulsed products of conception. Due to conflicts in the couple, she suspected a surreptitious administration of an abortion medicine and reported the fact to the police. Methods Urine was collected 3 days after the event, while a strand of head hair was collected 1 month later. Urine and hair samples were tested for mifepristone using a liquid chromatography system coupled to tandem mass spectrometry. The limits of detection and quantification were 0.05 and 0.1 ng/mL for urine and 0.5 and 1 pg/mg for hair, respectively. Results Urine and the hair segment corresponding to the period of the event were positive for mifepristone at 0.4 ng/mL and 1.4 pg/mg, respectively. Conclusion The presence of mifepristone in both biological specimens demonstrates that the woman was exposed to the drug at the period of the event. The findings of this case make a valuable contribution to the literature, addressing an important gap regarding the concentrations found in biological matrices. There is a few data available in the literature, and these results help to expand knowledge on the subject.
- Open Access
- 1 August 2024
- Published by Wiley in Drug Testing and Analysis
- Vol. 17 (6) , 779-785
Interest of hair tests to discriminate a tail end of a doping regimen from a possible contamination in case of challenging an anti‐doping rule violation. V. Case reports involving trimetazidine, a drug where the concentration after a single 20 mg dose has been established
The identification of trimetazidine, a medicine used for treating stable angina pectoris and for preventing angina attacks, has been recently observed in doping cases involving high profile athletes from various countries over the world. In all the files where the authors have been involved, the urine concentration of trimetazidine was low (no fault or negligence. When the delay between the urine collection and the notification of the violation was not too long (less than 6 months), these athletes requested a head hair test. Trimetazidine was analyzed by an original LC–MS/MS method involving pH 9.5 borate buffer overnight incubation of 20 mg and subsequent solvents extraction in presence of trimetazidine‐D8 used as internal standard. Linearity was verified from 1 to 200 pg/mg (R2 = 0.9987). Limit of detection of the method was 0.1 pg/mg. The hair specimen of a male subject, collected 4 weeks after single oral ingestion of 20 mg trimetazidine, tested positive at 146 pg/mg in the corresponding segment. Concentrations of trimetazidine measured in several hair specimens (n = 5) collected from athletes challenging their anti‐doping rule violation were below 1 pg/mg, which is consistent with incidental exposure due to contamination. This is the first evidence that trimetazidine is incorporated in human hair after a single therapeutic dose administration.
- 1 August 2024
- Published by Wiley in Drug Testing and Analysis
- Vol. 17 (6) , 779-785
Open AccessInterest of hair tests to discriminate a tail end of a doping regimen from a possible contamination in case of challenging an anti‐doping rule violation. V. Case reports involving trimetazidine, a drug where the concentration after a single 20 mg dose has been established
The identification of trimetazidine, a medicine used for treating stable angina pectoris and for preventing angina attacks, has been recently observed in doping cases involving high profile athletes from various countries over the world. In all the files where the authors have been involved, the urine concentration of trimetazidine was low (no fault or negligence. When the delay between the urine collection and the notification of the violation was not too long (less than 6 months), these athletes requested a head hair test. Trimetazidine was analyzed by an original LC–MS/MS method involving pH 9.5 borate buffer overnight incubation of 20 mg and subsequent solvents extraction in presence of trimetazidine‐D8 used as internal standard. Linearity was verified from 1 to 200 pg/mg (R2 = 0.9987). Limit of detection of the method was 0.1 pg/mg. The hair specimen of a male subject, collected 4 weeks after single oral ingestion of 20 mg trimetazidine, tested positive at 146 pg/mg in the corresponding segment. Concentrations of trimetazidine measured in several hair specimens (n = 5) collected from athletes challenging their anti‐doping rule violation were below 1 pg/mg, which is consistent with incidental exposure due to contamination. This is the first evidence that trimetazidine is incorporated in human hair after a single therapeutic dose administration.
- Open Access
- 11 July 2024
- Published by Wiley in Drug Testing and Analysis
- Vol. 17 (5) , 647-654
Simultaneous detection of three hypoxia‐inducible factor stabilizers—molidustat, roxadustat, and vadadustat—in multiple keratinized matrices and its application in a doping context
In a doping case, a top athlete challenged an anti‐doping rule violation, involving molidustat. Molidustat is a stabilizing agent of the hypoxia‐inducible factor (HIF) recently developed. It is currently undergoing clinical trials for anemia associated with chronic kidney disease. HIF stabilizers are banned at all times by the World Anti‐Doping Agency (class S2). Because of their pharmacological proprieties, these new drugs can enhance athletic performance. The athlete's defense wanted to analyze multiple keratinized matrices as they allow long‐term investigations. Requests concerning HIF stabilizers are constantly growing. We have therefore developed a liquid chromatography coupled with tandem mass spectrometry method to identify and quantify three molecules of this class: molidustat, vadadustat, and roxadustat. Thirty milligrams of keratinized matrices were incubated in 1 mL of pH 8.4 diammonium hydrogen phosphate buffer for 16 h at 40°C with 1 ng of testosterone‐D3, used as internal standard. After extraction with ethyl acetate/diethyl ether (80/20), the organic phase was evaporated, and the dry residue was reconstituted in 30 μL of initial phase. The method was linear from 5 to 1000 pg/mg for the three analytes. Limits of quantification were 2, 0.5, and 5 pg/mg for molidustat, roxadustat, and vadadustat, respectively. The analysis of the athlete's head hair (collected 1 month after the urine test) showed a concentration of molidustat of 135 pg/mg, and his beard hair and his fingernails clippings contained 55 and 40 pg/mg, respectively.
- 11 July 2024
- Published by Wiley in Drug Testing and Analysis
- Vol. 17 (5) , 647-654
Open AccessSimultaneous detection of three hypoxia‐inducible factor stabilizers—molidustat, roxadustat, and vadadustat—in multiple keratinized matrices and its application in a doping context
In a doping case, a top athlete challenged an anti‐doping rule violation, involving molidustat. Molidustat is a stabilizing agent of the hypoxia‐inducible factor (HIF) recently developed. It is currently undergoing clinical trials for anemia associated with chronic kidney disease. HIF stabilizers are banned at all times by the World Anti‐Doping Agency (class S2). Because of their pharmacological proprieties, these new drugs can enhance athletic performance. The athlete's defense wanted to analyze multiple keratinized matrices as they allow long‐term investigations. Requests concerning HIF stabilizers are constantly growing. We have therefore developed a liquid chromatography coupled with tandem mass spectrometry method to identify and quantify three molecules of this class: molidustat, vadadustat, and roxadustat. Thirty milligrams of keratinized matrices were incubated in 1 mL of pH 8.4 diammonium hydrogen phosphate buffer for 16 h at 40°C with 1 ng of testosterone‐D3, used as internal standard. After extraction with ethyl acetate/diethyl ether (80/20), the organic phase was evaporated, and the dry residue was reconstituted in 30 μL of initial phase. The method was linear from 5 to 1000 pg/mg for the three analytes. Limits of quantification were 2, 0.5, and 5 pg/mg for molidustat, roxadustat, and vadadustat, respectively. The analysis of the athlete's head hair (collected 1 month after the urine test) showed a concentration of molidustat of 135 pg/mg, and his beard hair and his fingernails clippings contained 55 and 40 pg/mg, respectively.
- Open Access
- 14 March 2024
- Published by Wiley in Journal of Forensic Sciences
- Vol. 69 (3) , 1106-1113
Is it really possible to kill with insulin without leaving traces? From lifesaver to killer, the issues surrounding the analytical characterization of postmortem insulin illustrated by an exemplary case
Evidence of an insulin overdose is very complicated in the medico‐legal field. The analysis and subsequent interpretation of results is complex, especially when treating postmortem blood samples. The instability of insulin, the special pre‐analytical conditions and the absence of specific analytical methods has led most laboratories not to analyze insulin in their routine with a consequent underestimation of cases. This paper aims to assess the difficulties associated with the analytical characterization of insulin by describing a case that typically represents most of the inconveniences encountered following a suspected insulin overdose. The case concerns a man found dead at home by his brother. After an external examination, which did not reveal a specific cause of death, toxicological analysis was requested which did not reveal any substance of toxicological interest. Only 9 months later, it was reported to the toxicologist that the subject was diabetic, on insulin lispro treatment and that three empty syringes were found next to his body. Following analysis by LC‐high‐resolution mass spectrometry, the presence of insulin lispro at a concentration of 1.1 ng/mL, a therapeutic concentration, was evidenced. Despite the low concentration found, overdose cannot be excluded and this paper will describe the criteria evaluated to reach this conclusion. This case highlights that the interpretation of a postmortem insulin concentration is very complex and requires the evaluation of various elements including the circumstances of death, the subject's medical history, the interval between death and sampling and the sample storage.
- 14 March 2024
- Published by Wiley in Journal of Forensic Sciences
- Vol. 69 (3) , 1106-1113
Open AccessIs it really possible to kill with insulin without leaving traces? From lifesaver to killer, the issues surrounding the analytical characterization of postmortem insulin illustrated by an exemplary case
Evidence of an insulin overdose is very complicated in the medico‐legal field. The analysis and subsequent interpretation of results is complex, especially when treating postmortem blood samples. The instability of insulin, the special pre‐analytical conditions and the absence of specific analytical methods has led most laboratories not to analyze insulin in their routine with a consequent underestimation of cases. This paper aims to assess the difficulties associated with the analytical characterization of insulin by describing a case that typically represents most of the inconveniences encountered following a suspected insulin overdose. The case concerns a man found dead at home by his brother. After an external examination, which did not reveal a specific cause of death, toxicological analysis was requested which did not reveal any substance of toxicological interest. Only 9 months later, it was reported to the toxicologist that the subject was diabetic, on insulin lispro treatment and that three empty syringes were found next to his body. Following analysis by LC‐high‐resolution mass spectrometry, the presence of insulin lispro at a concentration of 1.1 ng/mL, a therapeutic concentration, was evidenced. Despite the low concentration found, overdose cannot be excluded and this paper will describe the criteria evaluated to reach this conclusion. This case highlights that the interpretation of a postmortem insulin concentration is very complex and requires the evaluation of various elements including the circumstances of death, the subject's medical history, the interval between death and sampling and the sample storage.
- 14 February 2024
- Published by Wiley in Drug Testing and Analysis
- Vol. 16 (11) , 1366-1369
Interest of hair tests to discriminate a tail end of a doping regimen from a meat contamination in case of challenging an antidoping rule violation. III. Case report involving boldenone
- 14 February 2024
- Published by Wiley in Drug Testing and Analysis
- Vol. 16 (11) , 1366-1369
Interest of hair tests to discriminate a tail end of a doping regimen from a meat contamination in case of challenging an antidoping rule violation. III. Case report involving boldenone
- 21 December 2023
- Published by Wiley in Drug Testing and Analysis
- Vol. 16 (10) , 1074-1076
Does a hair test allow discriminating a tail end of a doping regimen from a contamination in case of challenging an anti‐doping rule violation? II. Case report involving chlortalidone
- 21 December 2023
- Published by Wiley in Drug Testing and Analysis
- Vol. 16 (10) , 1074-1076
Does a hair test allow discriminating a tail end of a doping regimen from a contamination in case of challenging an anti‐doping rule violation? II. Case report involving chlortalidone